| Teva Pharmaceutical Industries Limited (TEVA) | |||
|---|---|---|---|
| 8.25 -0.2 (-2.37%) | 06-24 16:01 | ||
| Open: | 8.61 | Pre. Close: | 8.45 |
| High: | 8.61 | Low: | 8.185 |
| Volume: | 16,381,568 | Market Cap: | 9013M |
| Price Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 8.621 - 8.663 | 8.663 - 8.704 |
| Low: | 8.07 - 8.121 | 8.121 - 8.171 |
| Close: | 8.155 - 8.236 | 8.236 - 8.317 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 12.25 One year: 14.07 |
| Support: | Support1: 7.96 Support2: 6.62 |
| Resistance: | Resistance1: 10.49 Resistance2: 12.05 |
| Pivot: | 8.75 |
| Moving Averages: | MA(5): 8.27  MA(20): 8.84 MA(100): 14.30 MA(250): 18.60 |
| MACD: | MACD(12,26): Signal(12,26,9): -1.12 |
| %K %D: | %K(14,3): 17.80 %D(3): 15.93 |
| RSI: | RSI(14): 28.29 |
| 52-Week: | High: 25.96 Low: 7.96 Change(%): -65.0 |
| Average Vol(K): | 3-Month: 1682239 10-Days: 1757190 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.TEVA has closed above bottom band by 26.2%. Bollinger Bands are 26.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Stock News |
|---|
|
Mon, 24 Jun 2019 16:11:51 Z Allergan's Botox Wins FDA Nod for Upper Limb Spasticity in Kids Thu, 20 Jun 2019 23:33:31 Z Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know Tue, 18 Jun 2019 16:41:21 Z iShares Core MSCI EAFE ETF Experiences Big Outflow Tue, 18 Jun 2019 15:34:40 Z Jazz's (JAZZ) New Sleep Drug Sunosi Gets Schedule IV Status Mon, 17 Jun 2019 12:58:06 Z Pre-Market Most Active for Jun 17, 2019 : ARRY, BYND, QQQ, BP, CHWY, AMD, QURE, ECA, FB, TEVA, GE, NLY |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency | |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency | |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Specialty Generic | |
| Shares Out. (M) | 1090.00 |
| Shares Float (M) | 1000.00 |
| % Held by Insiders | 3.95 |
| % Held by Institutions | 63.54 |
| Shares Short (K) | 17840 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | -3.420 |
| EPS Est. Current Year | 4.230 |
| EPS Est. Next Year | 3.690 |
| EPS Est. Next Quarter | 1.090 |
| Forward EPS | 2.790 |
| Book Value (p.s.) | 13.500 |
| PEG Ratio | -3.33 |
| Profit Margin | -18.66 |
| Operating Margin | 14.85 |
| Return on Assets (ttm) | 2.6 |
| Return on Equity (ttm) | -20.6 |
| Qtrly Rev. Growth | -15.2 |
| Gross Profit (p.s.) | 7.615 |
| Sales Per Share | |
| EBITDA (p.s.) | 4.092 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | 1060.00 |
| Levered Free Cash Flow (M) | 1900.00 |
| Stock Valuation | |
|---|---|
| P/E | -2.41 |
| P/E Growth Ratio | -0.02 |
| P/BV | 0.61 |
| P/S | 516810304.00 |
| P/CF | 8.48 |
| Dividend Yield | |
| Dividends & Splits | |
|---|---|
| Dividend | |
| Dividend Pay Date | 2017-12-12 |
| Ex-Dividend Date | 2017-11-27 |
| Forward Dividend | |
| Last Split Date | |
| Last Split Ratio | -1e+010 |
